Eterna Therapeutics (ERNA) Stock Chart & Stock Price History $0.23 0.00 (-1.05%) As of 10:48 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eterna Therapeutics Stock Price Performance The Eterna Therapeutics (ERNA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.64%, with a year-to-date return of -23.13%. In the past month, the stock has increased 16.62%, reflecting recent market activity. As of the latest close, Eterna Therapeutics traded at $0.23 with a market cap of $14.24 million and volume of 125,174 shares. Receive ERNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.89%1 Month Performance+16.62%3 Month Performance-28.23%Year-To-Date Performance-23.13%1 Year Performance-88.64% ERNA Stock Chart for Friday, May, 23, 2025 ERNA Chart by TradingView Eterna Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.23$0.23-0.70%$0.24$0.21125,174 shs$14.24 million05/21/2025$0.24$0.23-3.89%$0.25$0.22153,698 shs$14.34 million05/20/2025$0.23$0.24+4.04%$0.24$0.2381,565 shs$14.92 million05/19/2025$0.22$0.23+2.68%$0.24$0.2250,014 shs$14.34 million05/16/2025$0.23$0.22-4.27%$0.24$0.2271,133 shs$13.97 million05/15/2025$0.25$0.23-5.53%$0.25$0.21438,757 shs$14.59 million05/14/2025$0.22$0.25+13.11%$0.27$0.21685,160 shs$15.45 million05/13/2025$0.21$0.22+4.29%$0.22$0.20345,185 shs$13.66 million05/12/2025$0.20$0.21+6.11%$0.21$0.2082,559 shs$13.10 million05/09/2025$0.20$0.20-1.00%$0.20$0.1952,075 shs$10.34 million Get the Latest News and Ratings for ERNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.21$0.20-3.43%$0.22$0.20188,489 shs$10.44 million05/07/2025$0.21$0.21+0.98%$0.21$0.2029,929 shs$10.82 million05/06/2025$0.20$0.21+3.54%$0.21$0.2053,190 shs$10.71 million05/05/2025$0.20$0.20-2.22%$0.21$0.19215,266 shs$10.35 million05/02/2025$0.20$0.20+3.16%$0.21$0.2088,632 shs$10.58 million05/01/2025$0.21$0.20-5.17%$0.22$0.19137,129 shs$10.26 million04/30/2025$0.21$0.21-0.48%$0.22$0.2052,021 shs$10.82 million04/29/2025$0.21$0.21-1.65%$0.23$0.19390,160 shs$10.87 million04/28/2025$0.22$0.21-2.08%$0.23$0.20258,867 shs$11.05 million04/25/2025$0.20$0.22+5.42%$0.22$0.19210,780 shs$11.29 million04/24/2025$0.19$0.20+5.73%$0.21$0.19185,065 shs$10.71 million04/23/2025$0.18$0.19+5.21%$0.20$0.19155,686 shs$10.13 million04/22/2025$0.18$0.18+3.02%$0.19$0.1793,641 shs$9.62 million Related Companies BMEA Stock Price Chart IMRX Stock Price Chart OKYO Stock Price Chart IKNA Stock Price Chart CUE Stock Price Chart PRLD Stock Price Chart ATNM Stock Price Chart STTK Stock Price Chart RENB Stock Price Chart HOWL Stock Price Chart Receive ERNA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eterna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ERNA) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eterna Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eterna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ERNA Stock Free ERNA Stock Alerts